Why doesn't mild cognitive impairment strongly predict synucleinopathy conversion in RBD?

OPEN

Counterintuitively, mild cognitive impairment showed only weak predictive value (HR 1.8) compared to motor and sensory markers. This contradicts expectations given cognitive decline's prominence in Lewy body diseases and warrants mechanistic investigation. Gap type: contradiction Source paper: Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. (2015, Neurology, PMID:25681454)

Priority: 0.71 Domain: neurodegeneration Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: Why doesn't mild cognitive impairment strongly predict synucleinopathy conversion in RBD? is a 0.71 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why doesn't mild cognitive impairment strongly predict synucleinopathy conversion in RBD? — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.00

Avg Quality

Resolution

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps